S.4201

Authorizes coverage of prescriptive hormone replacement therapy.

Introduced·5/11/26
Introduced Text

New Jersey S4201 authorizes coverage of prescriptive hormone replacement therapy.

New Jersey S4201 mandates that health benefits plans, contracts, and Medicaid provide coverage for a 12-month refill of prescription hormone replacement therapy if the therapy does not require refrigeration. It allows for drug utilization management strategies and temporary refill limits during acute shortages. The act takes effect immediately for plans and contracts issued or renewed after enactment.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Commerce Committee
Next
Committee decision

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

History

May 11

Senate

Introduced in the Senate, Referred to Senate Commerce Committee